Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue, net $ 10,377 $ 9,833
Cost of revenue (excluding amortization of $536 and $1,112, respectively) 5,384 5,316
Gross profit 4,993 4,517
Operating expenses:    
Sales and marketing 2,416 2,351
Research and development 299 637
General and administrative 3,690 2,979
Transition expense 85 1,253
Acquisition related amortization expense 536 1,112
Total operating expenses 7,026 8,332
Operating loss (2,033) (3,815)
Interest accretion expense (121) (135)
Related party interest (92)
Note payable interest (180)
Other income (expense), net 159 (96)
Loss from continuing operations before tax (2,175) (4,138)
Provision for income taxes 18 15
Loss from continuing operations (2,193) (4,153)
Loss from discontinued operations, net of tax (54) (54)
Net loss $ (2,247) $ (4,207)
Basic and diluted loss per share of common stock:    
From continuing operations $ (0.52) $ (1.02)
From discontinued operations (0.01) (0.01)
Net loss per basic and diluted share of common stock $ (0.53) $ (1.03)
Weighted average number of common shares and common share equivalents outstanding:    
Basic 4,208 4,089
Diluted 4,208 4,089